Omeprazole administration in preterm preeclampsia: a randomized controlled trial to study its effect on sflt-1 (soluble fms-like tyrosine kinase-1), plgf (placental growth factor), and et-1 (endothelin-1)

HIGHLIGHTS

• who: Hypertension and collaborators from the This was a randomized controlled trial with individual randomization to the omeprazole group or non-omeprazole group according to GAIt was registered in the European Clinical Trials register, with protocol code number, . The trial was performed at , maternity units in Rotterdam, the Netherlands have published the Article: Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1), in the Journal: (JOURNAL) of August/30,/2022
• what: In the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.